Should angiotensin converting enzyme inhibitors be used in children with type 1 diabetes and microalbuminuria?

被引:4
|
作者
Almerie, M. Q. [1 ]
Williams, R. M. [1 ]
Acerini, C. L. [1 ]
机构
[1] Univ Cambridge, Dept Paediat, Addenbrookes Hosp, Cambridge, England
关键词
D O I
10.1136/adc.2008.138982
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:633 / 635
页数:3
相关论文
共 50 条
  • [21] Are angiotensin-converting enzyme inhibitors the best treatment for hypertension in type 2 diabetes?
    Komers, R
    Anderson, S
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2000, 9 (02): : 173 - 179
  • [22] Angiotensin-converting enzyme inhibition by quinapril blocks the albuminuric effect of atrial natriuretic peptide in Type 1 diabetes and microalbuminuria
    McKenna, K
    Smith, D
    Barrett, P
    Glenn, A
    Kesson, CM
    Connell, J
    Thompson, CJ
    DIABETIC MEDICINE, 2000, 17 (03) : 219 - 224
  • [23] Treatment of microalbuminuria with angiotensin coverting enzyme inhibitors (ACE-1) in type 1 diabetes: Are clinical guidelines being followed?
    Ficociello, L
    Perkins, B
    Silva, K
    Warram, J
    Krolewski, A
    DIABETES, 2003, 52 : A261 - A261
  • [24] Angiotensin-converting enzyme gene polymorphism and lipid profiles in Kuwaiti children with type 1 diabetes
    Alsaeid, M
    Moussa, MAA
    Haider, MZ
    Refai, TMK
    Abdella, N
    Al-Sheikh, N
    Gomez, JE
    PEDIATRIC DIABETES, 2004, 5 (02) : 87 - 94
  • [25] The renoprotective action of angiotensin-converting enzyme inhibitors in diabetes
    Ruggenenti, P
    Remuzzi, G
    EXPERIMENTAL NEPHROLOGY, 1996, 4 : 53 - 60
  • [26] Angiotensin-converting enzyme inhibitors and renal failure in diabetes
    Hiremath, S.
    Zimmerman, D.
    Knoll, G. A.
    KIDNEY INTERNATIONAL, 2006, 70 (07) : 1377 - 1377
  • [27] INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME
    BRUNNER, HR
    NUSSBERGER, J
    WAEBER, B
    ISI ATLAS OF SCIENCE-PHARMACOLOGY, 1987, 1 (01): : 8 - 12
  • [28] Treatment decisions in hypertension - or angiotensin converting enzyme inhibitors should be preferred?
    Czarnecka, Danuta
    KARDIOLOGIA POLSKA, 2013, 71 : 8 - 10
  • [29] Optimal strategies for preventing progression of renal disease: Should angiotensin converting enzyme inhibitors and angiotensin receptor blockers be used together?
    Komers R.
    Anderson S.
    Current Hypertension Reports, 2000, 2 (5) : 465 - 472
  • [30] Angiotensin converting enzyme and angiotensin converting enzyme inhibitors in dermatology: a narrative review
    Lo, Yang
    Tsai, Tsen-Fang
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (01) : 33 - 42